Design and Functional Evaluation of Albumin Mutants for Improving Medicinal Efficacy
Design and Functional Evaluation of Albumin Mutants for Improving Medicinal Efficacy
批准号:
10557245
负责人:
OTAGIRI Masaki
金额:
$6.85万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This investigation was undertaken to develop a safe and effective albumin using site-directed mutagenesis techniques. The results obtained in this study are as follow :1) Two single-mutants (K199A, K525A) were produced. The recombinant albumins were correctly folded, as evidenced by the fact that they showed similar patterns as the native albumin in the far- and near-UV CD spectrum as well as reactivity towards polyclonal anti-serum raised against native albumin.2) Thermal denaturation experiments by using GdnCl and DSC revealed no significant difference in conformational stability for native and mutant albumins.3) The ligand binding properties and esterase-like activity of the albumin mutants were nearly the same as those for the native albumin.4) The plasma levels of the albumin mutants labeled with ^<125>I after intravenous bolus injections to rats showed two-phase profiles but their half-lives were shorten than that for the native albumin.From the above results, there are potentials for the design of such albumin mutants but further investigations need to be carried out in order to serve the objectives of better safety and efficacy of albumin preparation.
期刊论文(68)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
T.Sakai et al: "Interaction between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of HSA"Pharmaceutical Research. 18(4)(in press). (2001)
T.Sakai 等人:“硫酸吲哚酚(一种与位点 II 结合的典型尿毒症毒素)与与 HSA 位点 I 结合的配体之间的相互作用”药物研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
丸山徹,小田切優樹(分担)沢田康文 他(編集): "医薬品の適正使用のための臨床薬物動態"じほう. 834 (2000)
Toru Maruyama、Yuki Odagiri(撰稿人)、Yasufumi Sawada 等人(编辑):“正确使用药物的临床药代动力学”Jiho 834 (2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Y.Tsutsumi: "Interaction between two carboxylate endogeneous substances,bilirubin and an uremic toxin,CMPF,on human serum albumin" Pharmaceutical Research. 16(6)(in press). (1999)
Y.Tsutsumi:“两种羧酸内源性物质胆红素和尿毒症毒素 CMPF 对人血清白蛋白的相互作用”药物研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Watanabe et al: "Conformational stability and warfarin binding properties of human serum albumin studied by recombinant mutants"Biochemical Journal. (in press). (2001)
H.Watanabe 等人:“重组突变体研究的人血清白蛋白的构象稳定性和华法林结合特性”生物化学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Watanabe H, et al.: "Role of arg-410 and tyr-411 in human serum albumin for ligand binding and esterase-like activity."Biochem J.. 349(3). 813-9 (2000)
Watanabe H 等人:“arg-410 和 tyr-411 在人血清白蛋白中对于配体结合和酯酶样活性的作用。”Biochem J.. 349(3)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 31 条
Development of novel hybrid anti-oxidant based on albumin fusion technology and its therapeutic application on acute radiation syndrome
-
批准号:15K15008
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2015
-
负责人:OTAGIRI Masaki
-
依托单位:
Construction of an Innovative Bone Marrow Delivery System of Anticancer Drug for Control of Malignant Tumors' Bone Metastasis
-
批准号:25670085
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2013
-
负责人:OTAGIRI Masaki
-
依托单位:
Design and Evaluation of Next Generation Albumin-thioredoxin Fusion Protein for Multiple Organ Failure Treatment
-
批准号:24390043
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.06万
-
财政年份:2012
-
负责人:OTAGIRI Masaki
-
依托单位:
Development of effective blood purification treatment method usingHSA bound toxic comnpodus designed bpyhase display tecnohlogy
-
批准号:23659088
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:OTAGIRI Masaki
-
依托单位:
Development of Redox Controlling Nanomedicine Based on Albumin Fusion
-
批准号:21390177
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.23万
-
财政年份:2009
-
负责人:OTAGIRI Masaki
-
依托单位:
Application of functional recombinant HSAs as a DDS carrier
-
批准号:18390051
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.09万
-
财政年份:2006
-
负责人:OTAGIRI Masaki
-
依托单位:
The development of next-generation albumin preparation by mutagenesi s studies
-
批准号:14370759
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.58万
-
财政年份:2002
-
负责人:OTAGIRI Masaki
-
依托单位:
Design and Evaluation of Albumin Mutants for Clinical Application
-
批准号:11694298
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$4.67万
-
财政年份:1999
-
负责人:OTAGIRI Masaki
-
依托单位:
Topology Analysis of Drug Binding Sites on Serum Proteins using Photoaffinity Labeling Techniques
-
批准号:09470505
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.17万
-
财政年份:1997
-
负责人:OTAGIRI Masaki
-
依托单位:
Development of Pharmaceutical Additives-Evaluation of Protein and Polysaccharide Hydrolysates as Carrier to Enhance Absorption Rate of Drug
-
批准号:07557146
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$2.37万
-
财政年份:1995
-
负责人:OTAGIRI Masaki
-
依托单位:
Microenviromental Analysis of Drug Binding Site on Albumin by Point-mutation and Using Probe
-
批准号:06672146
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.54万
-
财政年份:1994
-
负责人:OTAGIRI Masaki
-
依托单位:
Microenvironmental Analysis of Drug Binding Sites on Human Serum Albumin and alpha_1-Acid Glycoprotein
-
批准号:02807196
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.02万
-
财政年份:1990
-
负责人:OTAGIRI Masaki
-
依托单位:
海外基金